The head of one of the world's largest pharmaceutical companies has ruled out donations of vaccines to protect the poor against the latest flu pandemic, saying that developing countries or donor nations should cover the costs.

Daniel Vasella, chief executive of Novartis, based in Switzerland, told the FT he would consider offering discounted pricing on flu vaccines to low-income nations, but said: "If you want to make production sustainable, you have to create financial incentives."